Cart
sales@molnova.com
CYP1B1-IN-1
CAS No. 842122-33-2
CYP1B1-IN-1( —— )
Catalog No. M35463 CAS No. 842122-33-2
CYP1B1-IN-1 is a selective and highly potent cytochrome P450 1B1 (CYP1B1) inhibitor with potential anticancer and antitumor activity for breast cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1017 | In Stock |
|
| 10MG | 1359 | In Stock |
|
| 25MG | 2024 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCYP1B1-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCYP1B1-IN-1 is a selective and highly potent cytochrome P450 1B1 (CYP1B1) inhibitor with potential anticancer and antitumor activity for breast cancer research.
-
DescriptionCYP1B1-IN-1 (Compound 9e) is a selective cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 0.49 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorP450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number842122-33-2
-
Formula Weight306.74
-
Molecular FormulaC19H11ClO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=C(OC2=C1C=CC=3C=CC=CC32)C=4C=CC=C(Cl)C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dong J, et al. Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors. Eur J Med Chem. 2020 Feb 1;187:111938. ?
molnova catalog
related products
-
Apigenin
Apigenin is a potent P450 inhibitor for CYP2C9 with Ki of 2 μM.
-
Ellagic Acid Dihydra...
Ellagic Acid Dihydrate inhibit the CYP1A1-dependent activation of benzo[a]pyrene.
-
Anemosapogenin
Anemosapogenin shows potent anti-tumor effect in vivo, but it has some toxicity, structure modification should be needed.
